FBRX
Forte Biosciences, Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $0.00 | — | — |
| Two Sigma Investments re-entered | Q3 2024(8Q snapshot) | 7Q | $0.00 | — | — |
| Millennium Management | Q2 2025(8Q snapshot) | 4Q | $7.83 | $21 | +168% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Point72 Asset Management | Q1 2026 | Q2 2026 | → $23 | -22% |
| Renaissance Technologies 2× in & out | Q4 2025 | Q1 2026 | → $31 | +122% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Forte Biosciences, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 2, 2026 — the most recent Form 4 on file — not from today.
- Form 40001480111-26-000002Jun 2, 2026
- Form 40002038311-26-000002Jun 2, 2026
- Form 40001269341-26-000002Jun 2, 2026
- Form 40001202335-26-000002Jun 2, 2026
- Form 40001863614-26-000002Jun 2, 2026
- Form 40001814653-26-000002Jun 2, 2026
- Form 40001339375-26-000006Apr 3, 2026
- Form 40001612842-26-000006Apr 3, 2026
- Form 40001339375-26-000004Jan 13, 2026
- Form 40001612842-26-000004Jan 13, 2026
- Form 40001612842-26-000002Jan 2, 2026
- Form 40001339375-26-000002Jan 2, 2026
- Form 40001339375-25-000003Oct 2, 2025
- Form 40001612842-25-000003Oct 2, 2025
- Form 40001415889-25-019322Jul 3, 2025
Fundamentals
XBRL · Forte Biosciences, Inc.Annual figures sourced directly from Forte Biosciences, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Forte Biosciences, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- S-3/ARegistration (shelf, amended)Jun 8, 2026
- S-3Registration (shelf)Jun 2, 2026
- 8-KMaterial eventJun 2, 2026
- 8-KMaterial eventMay 14, 2026
- 10-QQuarterly reportMay 11, 2026
- DEF 14AProxy statementApr 29, 2026
- 8-KMaterial eventApr 9, 2026
- 8-KMaterial eventApr 1, 2026
- 10-KAnnual reportMar 31, 2026
- 10-QQuarterly reportNov 14, 2025
- 8-KMaterial eventNov 14, 2025
- 10-QQuarterly reportAug 14, 2025
- 8-KMaterial eventAug 14, 2025
- 8-KMaterial eventJun 25, 2025
- 8-KMaterial eventJun 23, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2026 | open | $23 | $21 | -9% |
| Two Sigma Investments | Q1 2026 | open | $30 | $21 | -30% |
| Point72 Asset Management | Q1 2026 | Q2 2026 | $30 | $23 | -22% |
| Citadel Advisors | Q4 2025 | Q1 2026 | $14 | $30 | +112% |
| Renaissance Technologies | Q4 2025 | Q1 2026 | $14 | $31 | +122% |
| Millennium Management | Q2 2025 | open | $7.83 | $21 | +168% |
| Citadel Advisors | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
| Two Sigma Investments | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
| Renaissance Technologies | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.